University of California, Davis

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of California, Davis sits in the top decile of US sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count).

657 total trials 123 currently recruiting 435 completed early-phase tilt top decile by trial count

University of California, Davis: 657 sponsored US clinical trials, 123 recruiting.

University of California, Davis sponsors 657 registered US clinical trials on ClinicalTrials.gov, 123 of them currently recruiting, and 435 completed. 38 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 12 trials.

Top-decile sponsor footprint

University of California, Davis ranks in the top decile of sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 65/100

435 of 483 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

657 total, page 5 of 14

COMPLETED NA

Effect of Insect-derived Protein Supplements on Protein Synthesis and mTORC1 Activation

NCT05457218
TERMINATED NA

Evaluation of Software Generated Customized Foot Orthoses

NCT05462912
TERMINATED Phase 1

Ascending Glycan Dietary Supplementation in Healthy Adults

NCT04466761
COMPLETED

Ventilation and Esophageal Pressure Changes

NCT05859672
COMPLETED NA

Stress Management and Resiliency Training Following Acute Myocardial Infarction

NCT05415735
COMPLETED NA

Vitamin/Mineral Absorption From Two Different Supplements

NCT05336994
COMPLETED NA

Pragmatic Trial of Text Messages to Recruit Unassisted Tobacco Users Into Quitline Service

NCT07102290
COMPLETED NA

Aesthetic Outcome of Complex Linear Closure vs Second Intention Healing: Below the Knee

NCT05074212
TERMINATED Phase 2

Atezolizumab Before Surgery for the Treatment of Regionally Metastatic Head and Neck Squamous Cell Cancer With an Unknown or Historic Primary Site

NCT05110781
TERMINATED NA

The Influence of Daily Strawberry Intake on Vascular Health in Elderly Men

NCT04763499
COMPLETED NA

Effects of Japanese Red Wines on Vascular Function in Adult Men

NCT05138939
COMPLETED NA

Aesthetic Outcome of Running Subcuticular Suture Versus Running Horizontal Mattress Suture Closure of Linear Wounds on the Trunk and Extremities

NCT05263713
COMPLETED NA

Improving Treatment-Related Symptom Management in Adolescents and Young Adults With Cancer

NCT04594096
COMPLETED NA

Brain Stimulation, Clinical Symptoms and Cognition

NCT05053451
COMPLETED

Surveying Nutrient Assessment With Photographs of Meals (SNAPMe) Study

NCT05008653
COMPLETED NA

EXPLORER PET/CT: Evaluation of Healthy Individuals From Racial/Ethnic Minority Populations

NCT04812080
COMPLETED NA

The Effect of Time-restricted Eating on Liver Metabolism

NCT04997486
COMPLETED NA

Online Network Intervention to Increase HIV Pre-exposure Prophylaxis Intention

NCT04771312
COMPLETED NA

Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS

NCT05233579
COMPLETED NA

Pilot Study of Remote Glucose Monitoring Among Pediatric Patients With Type 1 Diabetes

NCT04696640
COMPLETED Phase 1

Phase 1 Study of Intravitreal Autologous CD34+ Stem Cell Therapy for Retinitis Pigmentosa

NCT04925687
COMPLETED NA

The Effect of Topical Almond Oil vs. Topical Retinol on The Appearance of Facial Wrinkles

NCT05011461
COMPLETED NA

Total-Body Parametric 18F-FDG PET of COVID-19

NCT04841707
COMPLETED NA

Amino Acid Profile and Muscle Protein Synthetic Response to Consuming Meat or Plant-based Alternatives

NCT04784806
COMPLETED NA

Absorption and Digestion Kinetics of Human Metabolites

NCT05017428
COMPLETED Early Phase 1

[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients

NCT04678440
TERMINATED

Comparing Immune Responses to Topical Imiquimod

NCT04809662
COMPLETED

Arterial Pressure vs. TE Echo dp/dt

NCT04726852
COMPLETED NA

Healthy Moms: Prenatal Counseling for Postpartum Health

NCT04601987
COMPLETED Phase 1

Systemic and Local Levels of Lidocaine During Surgery for the Removal of Glioblastoma

NCT04716699
COMPLETED NA

Koa Family Study--A Community-Based Intervention to Improve Health and Well-Being

NCT04662593
COMPLETED NA

Goals for Reaching Optimal Wellness: GROWell

NCT04449432
COMPLETED NA

Aromatherapy for Management of Pain, Anxiety, and Nausea in the Acute Care Setting

NCT06400979
COMPLETED NA

Improving Family-Centered Pediatric Trauma Care: The Standard of Care Versus the Virtual Pediatric Trauma Center

NCT04469036
TERMINATED NA

The Effect of Time-Restricted Eating in Cardiometabolic Health

NCT04484987
COMPLETED Phase 2

Enhanced Recovery After Surgery in Orthopaedic Spine Surgery

NCT04562610
COMPLETED NA

Perceived Effectiveness of Added Sugar Labels

NCT04637412
COMPLETED NA

Physiology of GERD and Treatment Response

NCT04292470
COMPLETED NA

Watchful Waiting as a Strategy for Reducing Low-value Spinal Imaging

NCT04255199
COMPLETED NA

Diabetes Communication and Treatment Burden

NCT04568382
COMPLETED

Cardiovascular Effects of Prenatal Methamphetamine Exposure

NCT04616625
COMPLETED NA

Enhancing Electronic Health Systems to Decrease the Burden of Colon Cancer, Lung Cancer, Obesity, Vaccine-Preventable Illness, and LivER Cancer

NCT04540081
COMPLETED Phase 4

Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive

NCT04423055
COMPLETED NA

Pain Procedures and Anxiolysis Via Distraction With Virtual Reality

NCT04437173
COMPLETED NA

Breastfeeding Education in the Time of COVID-19

NCT04519216
COMPLETED NA

Using Kinect Motion Capture to Measure Shoulder Motion in Patients Undergoing Capsular Distension for Adhesive Capsulitis

NCT04413162
COMPLETED Early Phase 1

PET/CT Imaging in COVID-19 Patients

NCT04376593
COMPLETED NA

FamilyLink Family-Centered Rounds

NCT04265677
COMPLETED NA

Implementation of ABI and WIfI in Rural Health Clinics

NCT04337723
COMPLETED NA

Implementation of Telemedicine for Patient With Lower Extremity Wounds

NCT04440839
← Previous Page 5 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 86
Phase 2 43
Phase 3 10
Phase 4 28

Therapeutic Areas

Healthy 12
Obesity 8
Inflammation 5
Metabolic Syndrome 5
Autism Spectrum Disorder 5
Scarring 4
Breast Cancer 4
Lung Cancer 4
Psoriasis 4
Head and Neck Cancer 4

What is open in the University of California, Davis pipeline

123 recruiting of 657 indexed (19% open); 435 completed (66%).

Phase mix: 38 late (III/IV) vs 129 early (I/II) (early-phase heavy).

Top condition: Healthy (12 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of California, Davis: open-pipeline peers nationwide

Peers matched on 657 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0200400600800 0%5%10%15%20%25% Total trials Recruiting share University of California, DavisVanderbilt University Medical CenterUniversity of RochesterUS Department of Veterans AffairsThe Cleveland ClinicEyePoint PharmaceuticalsHebrew SeniorLifeInsulet CorporationMedical University of South Carolina
University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 657 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of California, Davis page

657 registered trials is a research-attention snapshot, not an endorsement of University of California, Davis or any single study.

  • 123 of University of California, Davis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Healthy is the condition University of California, Davis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

University of California, Davis pipeline card: 657 registered trials from official public datasets.Report a data error.